Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Mannucci, K. Schimpf, D. Brettler, N. Ciavarella, M. Colombo, F. Haschke, K. Lechner, J. Lusher, G. Weissbach (1990)
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.Annals of internal medicine, 113 1
M. Williams, S. Skidmore, F. Hill (1990)
HIV Seroconversion in Haemophilic Boys Receiving Heat‐Treated Factor VIII ConcentrateVox Sanguinis, 58
M. Horowitz, B. Horowitz, C. Rooks, M. Hilgartner (1988)
VIRUS SAFETY OF SOLVENT/DETERGENT-TREATED ANTIHAEMOPHILIC FACTOR CONCENTRATEThe Lancet, 332
Viral safety of solventidetergent treated FVIII concentrate: results of a French Multicenter Study. Abstract of the 18th International Congress of the world Federation of Hemophilia
Hanley Hanley, Lippman‐Hand Lippman‐Hand (1983)
If nothing is wrong, is everything all right?Journal of the American Medical Association, 249
(1983)
Lippman-Hand A (1983): If nothing is wrong, is everything all right
J. Kleim, E. Bailly, K. Schneweis, H. Brackmann, U. Hammerstein, P. Hanfland, Birgit Loo, J. Oldenburg (1990)
Acute HIV-1 Infection in Patients with Hemophilia B Treated with β-Propiolactone-UV-lnactivated Clotting FactorThrombosis and Haemostasis, 64
D. Vaira, C. François‐Gérard, B. Rentier, D. Sondag‐Thull (1989)
Absence of Seroconversion in a PCR‐Positive Person 18 Months after Transfusion of HIV‐Infected BloodVox Sanguinis, 57
S. Dietrich, J. Mosley, Jeanne Lusher, Margaret Hilgartner, E. Operskalski, L. Habel, L. Aledort, G. Gjerset, Marion Koerper, B. Lewis, C. Pegelow (1990)
Transmission of Human Immunodeficiency Virus Type 1 by Dry‐Heated Clotting Factor Concentrates 1Vox Sanguinis, 59
K. Schimpf, H. Brackmann, W. Kreuz, B. Kraus, F. Haschke, W. Schramm, J. Moesseler, G. Auerswald, A. Sutor, K. Koehler, P. Hellstern, W. Muntean, I. Scharrer (1989)
Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate.The New England journal of medicine, 321 17
K. Schimpf, P. Mannucci, W. Kreutz, H. Bragkmann, C. Auerswald, Nicola Ciavarella, J. Mößeler, V. Derosa, B. Kraus, Ch. Bruegkmann, G. Mancuso, U. Mittler, F. Haschke, Massimo Morfini (1987)
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.The New England journal of medicine, 316 15
J. Hanley, A. Lippman‐Hand (1983)
If nothing goes wrong, is everything all right? Interpreting zero numerators.JAMA, 249 13
J. Allain, D. Paul, Y. Laurian, D. Senn, Members Group (1986)
SEROLOGICAL MARKERS IN EARLY STAGES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HAEMOPHILIACSThe Lancet, 328
K. Schimpf, H. Brackmann, D. Bock, G. Landbeck, E. Lechler, H. Vinazzer (1987)
NO ANTI-HIV SEROCONVERSION AFTER REPLACEMENT THERAPY WITH STEAM-TREATED FACTOR VIII CONCENTRATE. A STUDY OF 60 PATIENTS WITH HEMOPHILIA A AND VON WILLEBRAND'S DISEASEThrombosis and Haemostasis, 58
D. Imagawa, H. LeeMoon, Steven Wolinsky, K. Sano, F. Morales, S. Kwok, J. Sninsky, P. Nishanian, Giorgi Jv, J. Fahey, J. Dudley, B. Visscher, R. Detels (1989)
Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.The New England journal of medicine, 320 22
A. Prince, B. Horowitz, B. Brotman (1986)
STERILISATION OF HEPATITIS AND HTLV-III VIRUSES BY EXPOSURE TO TRI(n-BUTYL)PHOSPHATE AND SODIUM CHOLATEThe Lancet, 327
Mannucci Mannucci, Schimpf Schimpf, Brettler Brettler, Ciavarella Ciavarella, Colombo Colombo, Haschke Haschke, Lechner Lechner, Lusher Lusher, Weissbach Weissbach (1990)
Low risk for hepatitis C in hemophiliacs given a high‐purity, pasteurized factor VIII concentrateAnnals of Internal Medicine, 113
(1990)
Follow up of hemophiliacs using solvent/detergent treated F VIII and F IX concentrates
B. Horowitz, M. Wiebe, A. Lippin, M. Stryker (1985)
Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 25
P. Mannucci, A. Zanetti, M. Colombo (1988)
Prospective study of hepatitis after factor VIII concentrate exposed to hot vapourBritish Journal of Haematology, 68
G. Mariani, A. Ghirardini, F. Mandelli, P. Verani, S. Buttò, G. Rossi, P. Mannucci (1987)
Heated clotting factors and seroconversion for human immunodeficiency virus in three hemophilic patients.Annals of internal medicine, 107 1
C. Hart, T. Spira, Jennifer Moore, J. Sninsky, G. Schochetman, A. Lifson, J. Galphin, C. Ou (1988)
DIRECT DETECTION OF HIV RNA EXPRESSION IN SEROPOSITIVE SUBJECTSThe Lancet, 332
M. Loche, B. Mach (1988)
IDENTIFICATION OF HIV-INFECTED SERONEGATIVE INDIVIDUALS BY A DIRECT DIAGNOSTIC TEST BASED ON HYBRIDISATION TO AMPLIFIED VIRAL DNAThe Lancet, 332
A study evaluating the risk of a commercial factor VIII (FVIII) concentrate's transmitting the human immunodeficiency virus (HIV) was carried out on hemophiliacs, by using multiple serological markers and the polymerase chain reaction (PCR). Twenty‐nine hemophiliacs, negative for HIV antibodies, were treated for 18 months with a concentrate that had been inactivated by solvent‐detergent. HIV‐1 antibodies and antigen were assayed during the follow‐up period. At the end of the study, all patients were also tested by the HIV 1+2 combined antibody assay; Western blot (WB) antibody analysis; and in eight cases, by an HIV‐1 PCR technique. Patients received a yearly median FVIII dose of 35,330 IU (range 3,300‐306,000); the median number of lots given to each patient was 6 (1‐45). During the follow‐up period and at the end of the study, HIV‐1 antibodies and antigen were not detected in any of the subjects. The HIV 1+2 combined assay and WB analysis carried out only at the end of the study were negative. HIV‐1 PCR was negative in all the tested patients. This study has shown that this solvent‐detergent‐treated FVIII concentrate did not transmit HIV.
Journal of Medical Virology – Wiley
Published: Feb 1, 1992
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.